| Dr Caesar Castro Agagan, MD | |
|
141 Tuscaloosa St, Mobile, AL 36607-3422 | |
| (251) 433-3344 | |
| (251) 433-4052 |
| Full Name | Dr Caesar Castro Agagan |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 141 Tuscaloosa St, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285610576 | NPI | - | NPPES |
| 213145 | Medicaid | AL | |
| 290014606 | Other | AL | RR MEDICARE |
| 512-05482 | Other | AL | BCBS |
| H29012 | Other | AL | VIVA HEALTH |
| 51507365 | Medicaid | AL | |
| 1987747 | Other | AL | UHC |
| 7608175 | Other | AL | AETNA |
| 213434 | Medicaid | AL | |
| 512-05483 | Other | AL | BCBS |
| 051507365 | Other | AL | MEDICARE |
| 1003499 | Other | AL | CIGNA HC |
| 221315 | Medicaid | AL | |
| 00124658 | Other | MS | MS MEDICAID |
| 220390 | Medicaid | AL | |
| 515-07365 | Other | AL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 23463 (Alabama) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 23463 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Springhill Medical Center | Mobile, AL | Hospital |
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| Atmore Community Hospital | Atmore, AL | Hospital |
| Washington County Hospital | Chatom, AL | Hospital |
| Thomas Hospital | Fairhope, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary Associates Of Mobile Pc | 3870571912 | 35 |
News Archive
Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced a collaboration with the Charcot-Marie-Tooth Association, a registered non-profit organization serving the hereditary neuropathy patient community, to validate the role of HDAC6 in multiple forms of Charcot-Marie-Tooth disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor, in animal models.
Researchers from Boston College have developed a new class of small molecule receptors capable of detecting a lipid molecule that reveals the telltale signs of cellular death, particularly cancer cells targeted by anti-cancer drugs, the team reports in the current electronic edition of the Journal of the American Chemical Society.
Stilla Technologies, the provider of pioneering digital PCR solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director.
Following the recent G20 side event co-hosted by the Italian Government and the United Nations World Food Programme (WFP) focusing on the role of logistics in current and future health emergencies, WFP and the World Health Organization (WHO) are launching INITIATE2, a joint project to bring together emergency actors, research and academic institutions, and international and national partners to promote knowledge sharing and skills transfer for improved emergency response to health crises.
The mortality rate in Massachusetts declined substantially in the four years after the state enacted a law in 2006 mandating universal health care coverage, providing the model for the Affordable Care Act.
› Verified 7 days ago
| Entity Name | Pulmonary Associates Of Mobile Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194776278 PECOS PAC ID: 3870571912 Enrollment ID: O20040713001400 |
News Archive
Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced a collaboration with the Charcot-Marie-Tooth Association, a registered non-profit organization serving the hereditary neuropathy patient community, to validate the role of HDAC6 in multiple forms of Charcot-Marie-Tooth disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor, in animal models.
Researchers from Boston College have developed a new class of small molecule receptors capable of detecting a lipid molecule that reveals the telltale signs of cellular death, particularly cancer cells targeted by anti-cancer drugs, the team reports in the current electronic edition of the Journal of the American Chemical Society.
Stilla Technologies, the provider of pioneering digital PCR solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director.
Following the recent G20 side event co-hosted by the Italian Government and the United Nations World Food Programme (WFP) focusing on the role of logistics in current and future health emergencies, WFP and the World Health Organization (WHO) are launching INITIATE2, a joint project to bring together emergency actors, research and academic institutions, and international and national partners to promote knowledge sharing and skills transfer for improved emergency response to health crises.
The mortality rate in Massachusetts declined substantially in the four years after the state enacted a law in 2006 mandating universal health care coverage, providing the model for the Affordable Care Act.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Caesar Castro Agagan, MD Po Box 7987, Mobile, AL 36670-0987 Ph: (251) 633-0573 | Dr Caesar Castro Agagan, MD 141 Tuscaloosa St, Mobile, AL 36607-3422 Ph: (251) 433-3344 |
News Archive
Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced a collaboration with the Charcot-Marie-Tooth Association, a registered non-profit organization serving the hereditary neuropathy patient community, to validate the role of HDAC6 in multiple forms of Charcot-Marie-Tooth disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor, in animal models.
Researchers from Boston College have developed a new class of small molecule receptors capable of detecting a lipid molecule that reveals the telltale signs of cellular death, particularly cancer cells targeted by anti-cancer drugs, the team reports in the current electronic edition of the Journal of the American Chemical Society.
Stilla Technologies, the provider of pioneering digital PCR solutions for high-precision genetic analysis, today announced three key hires: Khaled Bahi joins as CFO, with Jerome Leclercq named Senior Vice President for Commercial Operations Europe & Asia and Quang Tran named Quality & Regulatory Affairs Director.
Following the recent G20 side event co-hosted by the Italian Government and the United Nations World Food Programme (WFP) focusing on the role of logistics in current and future health emergencies, WFP and the World Health Organization (WHO) are launching INITIATE2, a joint project to bring together emergency actors, research and academic institutions, and international and national partners to promote knowledge sharing and skills transfer for improved emergency response to health crises.
The mortality rate in Massachusetts declined substantially in the four years after the state enacted a law in 2006 mandating universal health care coverage, providing the model for the Affordable Care Act.
› Verified 7 days ago
Damian Joseph Collins, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 Spring Hill Ave, Suite 100, Mobile, AL 36604 Phone: 251-435-1200 Fax: 251-435-6357 | |
Lenore Landers Pierce, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-639-5775 Fax: 251-631-3581 | |
Peter Chestnutt Coats, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 6701 Airport Blvd, Suite A-101, Mobile, AL 36608 Phone: 251-633-8880 Fax: 251-634-4502 | |
Mr. Stephen Reeves Dill, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 6801 Airport Blvd # 11n, Mobile, AL 36608 Phone: 251-445-2412 Fax: 850-981-1878 | |
Dr. Dale Scott Kirby Jr., MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Suite D-330, Mobile, AL 36608 Phone: 251-607-9797 Fax: 251-607-9761 | |
Sandeep Vidyadhar Bhadkamkar, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-266-3580 Fax: 251-266-3581 | |
Reynaldo Rodriguez, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 Springhill Business Park, Mobile, AL 36608 Phone: 251-873-6192 Fax: 251-873-6193 |